STAAR Surgical Company (STAA)
NASDAQ: STAA · Real-Time Price · USD
17.89
+0.49 (2.79%)
At close: Jun 6, 2025, 4:00 PM
17.65
-0.24 (-1.31%)
After-hours: Jun 6, 2025, 7:35 PM EDT
STAAR Surgical Company Market Cap
STAAR Surgical Company has a market cap or net worth of $884.75 million as of June 6, 2025. Its market cap has decreased by -57.64% in one year.
Market Cap
884.75M
Enterprise Value
698.66M
1-Year Change
-57.64%
Ranking
Category
Stock Price
$17.89
Market Cap Chart
Since December 1, 1998, STAAR Surgical Company's market cap has increased from $117.80M to $884.75M, an increase of 651.06%. That is a compound annual growth rate of 7.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 6, 2025 | 885.00M | -26.06% |
| Dec 31, 2024 | 1.20B | -21.44% |
| Dec 29, 2023 | 1.52B | -34.89% |
| Dec 30, 2022 | 2.34B | -46.16% |
| Dec 31, 2021 | 4.35B | 18.97% |
| Dec 31, 2020 | 3.65B | 132.83% |
| Dec 31, 2019 | 1.57B | 11.41% |
| Dec 31, 2018 | 1.41B | 120.72% |
| Dec 29, 2017 | 638.00M | 44.80% |
| Dec 30, 2016 | 440.60M | 54.71% |
| Dec 31, 2015 | 284.80M | -19.11% |
| Dec 31, 2014 | 352.10M | -41.69% |
| Dec 31, 2013 | 603.80M | 170.40% |
| Dec 31, 2012 | 223.30M | -41.02% |
| Dec 30, 2011 | 378.60M | 77.25% |
| Dec 31, 2010 | 213.60M | 98.33% |
| Dec 31, 2009 | 107.70M | 53.42% |
| Dec 31, 2008 | 70.20M | -9.54% |
| Dec 31, 2007 | 77.60M | -56.65% |
| Dec 29, 2006 | 179.00M | -8.63% |
| Dec 30, 2005 | 195.90M | 51.63% |
| Dec 31, 2004 | 129.20M | -37.61% |
| Dec 31, 2003 | 207.10M | 225.63% |
| Dec 31, 2002 | 63.60M | -3.78% |
| Dec 31, 2001 | 66.10M | -68.84% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 682.52B |
| Johnson & Johnson | 369.26B |
| AbbVie | 331.11B |
| Novo Nordisk | 324.15B |
| UnitedHealth Group | 271.51B |
| Abbott Laboratories | 231.95B |
| Novartis AG | 229.87B |
| AstraZeneca | 226.47B |